FDA 批准了 Magstim 的 Horizo​​n 3.0 与 StimGuide Pro，这是第一个具有导航功能的集成 TMS 系统，用于精确的经颅磁刺激治疗靶向。 FDA cleared Magstim's Horizon 3.0 with StimGuide Pro, the first integrated TMS system with navigation for precise transcranial magnetic stimulation treatment targeting.

FDA 已批准 Magstim 的 Horizo​​n 3.0 与 StimGuide Pro，标志着经颅磁刺激 (TMS) 技术的重大发展。 The FDA has granted clearance for Magstim's Horizon 3.0 with StimGuide Pro, marking a significant development for transcranial magnetic stimulation (TMS) technology. 带有 StimGuide Pro 的 Horizo​​n 3.0 是首款带导航功能的集成 TMS 系统，提供先进的摄像头技术和软件，可实现精确的治疗目标。 The Horizon 3.0 with StimGuide Pro is the first integrated TMS system with navigation, offering advanced camera technology and software for precise treatment targeting. 该系统在一个屏幕上简化了患者治疗和技术，降低了复杂性。 The system simplifies patient treatment and technology on one screen, reducing complexity. 它还具有蓝牙解剖指针，用于绘制地图和治疗患者。 It also features a Bluetooth anatomical pointer for mapping and treating patients. 非侵入性 TMS 方法使用电磁线圈刺激大脑情绪控制和抑郁区域的神经细胞，StimGuide Pro 的先进导航提高了线圈定位的准确性和可重复性。 The non-invasive TMS method uses an electromagnetic coil to stimulate nerve cells in the brain's mood control and depression regions, with StimGuide Pro's advanced navigation improving coil positioning for accuracy and repeatability.